Reglagene Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Angel
  • (Upcoming)
  • Latest Deal Amount
  • $1.5M
Latest Deal Amount
  • Investors
  • 5

Reglagene General Information

Description

Developer of Precision Chemotherapies intended to induce DNA damage in cancer cells while sparing healthy cells. The company creates medicines that leverage special DNA structures called quadruplexes that serve as master controllers of gene processing, enabling users to fight cancer and other diseases in which changes in gene processing rate are causal.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Pending Transaction (Angel)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1703 East Mabel Street
  • Tucson, AZ 85721
  • United States
+1 (520) 000-0000

Reglagene Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Reglagene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Angel (individual) $1.5M Upcoming Startup
7. Angel (individual) 13-Jul-2021 00000 00.000 Completed Startup
6. Grant 18-Feb-2020 00000 00000 Completed Startup
5. Grant 05-Apr-2019 00000 00000 Completed Startup
4. Grant 17-Sep-2018 00000 00000 Completed Startup
3. Angel (individual) 17-Aug-2018 00000 00000 Completed Startup
2. Grant 16-Feb-2018 $30K Completed Startup
1. Accelerator/Incubator 01-Jan-2017 Completed Startup
To view Reglagene’s complete valuation and funding history, request access »

Reglagene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of Precision Chemotherapies intended to induce DNA damage in cancer cells while sparing healthy cells. The com
Drug Discovery
Tucson, AZ
10 As of 2021
00.000
00000

000000 0

e magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip e
0000000000000
Watertown, MA
000 As of 0000
00000
00000000 00000

0000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitati
0000000000000
New Haven, CT
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Reglagene Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kymera Therapeutics Formerly VC-backed Watertown, MA 000 00000 00000000 00000
0000000 Formerly VC-backed New Haven, CT 000 00000 000000 - 000 00000
000000 00000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
000000 00000000 Formerly VC-backed Cambridge, MA 000 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Cambridge, MA 0000 00.000 000000000 00.000
To view Reglagene’s complete competitors history, request access »

Reglagene Executive Team (5)

Name Title Board Seat Contact Info
Richard Austin Ph.D Co-Founder, Chief Executive Officer, Board Member and President
Laurence Hurley Ph.D Co-Founder, Chief Scientific Officer & Board Member
Michael Abrahamson Manager, Business Development
Betty Weaver Chief Financial Officer
Vijay Gokhale Ph.D Co-Founder and Vice President of Discovery
To view Reglagene’s complete executive team members history, request access »

Reglagene Board Members (4)

Name Representing Role Since
David Bearss Ph.D Self Board Member 000 0000
Lawrence Kinet Reglagene Board Member 000 0000
Richard Austin Ph.D Reglagene Co-Founder, Chief Executive Officer, Board Member and President 000 0000
Sharon Ayd Ph.D Self Board Member 000 0000
To view Reglagene’s complete board members history, request access »

Reglagene Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reglagene Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National institutes of Neurological Disorders and Stroke Other 000 0000 000000 0
Desert Angels Angel Group Minority 000 0000 000000 0
Flinn Foundation Accelerator/Incubator 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
Arizona Center for Innovation Accelerator/Incubator 000 0000 000000 0
To view Reglagene’s complete investors history, request access »